These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25938048)

  • 1. Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea.
    Park YG; Kang S; Roh YJ
    Int J Ophthalmol; 2015; 8(2):315-20. PubMed ID: 25938048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intravitreal Brolucizumab in the Treatment of Polypoidal Choroidal Vasculopathy With Foveal Lipid Exudation.
    Carta V; Lixi F; Tatti F; Peiretti E
    Cureus; 2023 Oct; 15(10):e47942. PubMed ID: 38034243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy.
    Kimura M; Sakurada Y; Fukuda Y; Matsubara M; Kotoda Y; Kasai Y; Sugiyama A; Kikushima W; Tsuru DV; Kashiwagi K
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Effectiveness of Intravitreal Brolucizumab Injection in Combination With Sub-Tenon's Capsule Triamcinolone Acetonide Injection for Polypoidal Choroidal Vasculopathy During the Loading Phase.
    Yoshikawa Y; Sakaki Y; Shinoda K; Kataoka K
    Cureus; 2024 May; 16(5):e59481. PubMed ID: 38832144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ranibizumab for wet age-related macular degeneration in Chinese patients.
    Qi HJ; Li XX; Zhang JY; Zhao MW
    Int J Ophthalmol; 2017; 10(1):91-97. PubMed ID: 28149783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
    Yamamoto A; Okada AA; Kano M; Koizumi H; Saito M; Maruko I; Sekiryu T; Iida T
    Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy.
    Kuehlewein L; Sadda SR; Sarraf D
    Eye (Lond); 2015 Jul; 29(7):932-5. PubMed ID: 25976641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy.
    Wong IY; Shi X; Gangwani R; Zhao P; Iu LP; Li Q; Ng A; Li X
    BMC Ophthalmol; 2015 Jun; 15():66. PubMed ID: 26122636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration.
    Coscas G; Lupidi M; Coscas F; Benjelloun F; Zerbib J; Dirani A; Semoun O; Souied EH
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3187-95. PubMed ID: 26024102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab.
    Saunders DJ; Muether PS; Fauser S
    Br J Ophthalmol; 2015 Nov; 99(11):1554-9. PubMed ID: 25957377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.
    Ishibashi T; Li X; Koh A; Lai TY; Lee FL; Lee WK; Ma Z; Ohji M; Tan N; Cha SB; Shamsazar J; Yau CL;
    Ophthalmology; 2015 Jul; 122(7):1402-15. PubMed ID: 25983216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population.
    Basheer K; Mensah E; Khanam T; Minakaran N
    Clin Ophthalmol; 2015; 9():959-65. PubMed ID: 26060392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis.
    Sigford DK; Reddy S; Mollineaux C; Schaal S
    Clin Ophthalmol; 2015; 9():773-81. PubMed ID: 25999685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability.
    Nomura Y; Yanagi Y
    Jpn J Ophthalmol; 2015 Jul; 59(4):261-5. PubMed ID: 25983109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME).
    Korobelnik JF; Kleijnen J; Lang SH; Birnie R; Leadley RM; Misso K; Worthy G; Muston D; Do DV
    BMC Ophthalmol; 2015 May; 15():52. PubMed ID: 25975823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography and multifocal electroretinography of patients with advanced neovascular age-related macular degeneration before, during, and after treatment with ranibizumab.
    Almeida IN; Almeida LN; Almeida Sobrinho EF; Gomes BD; Souza Gda S; Rosa AA; Silveira LC
    Arq Bras Oftalmol; 2015; 78(2):105-9. PubMed ID: 25945532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice.
    Despreaux R; Cohen SY; Semoun O; Zambrowski O; Jung C; Oubraham H; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):639-44. PubMed ID: 26092633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration.
    Yazdi MH; Faramarzi MA; Nikfar S; Falavarjani KG; Abdollahi M
    Expert Opin Biol Ther; 2015; 15(9):1349-58. PubMed ID: 26076760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience With Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration.
    He L; Silva RA; Ayoub N; Moshfeghi DM; Leng T
    Ophthalmic Surg Lasers Imaging Retina; 2015 May; 46(5):542-9. PubMed ID: 26057757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration.
    Gohil R; Crosby-Nwaobi R; Forbes A; Burton B; Hykin P; Sivaprasad S
    PLoS One; 2015; 10(6):e0129361. PubMed ID: 26056840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.